Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Nonproliferative Diabetic Retinopathy”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Post-approval studies (Phase 4)WithdrawnNCT04702048
What this trial is testing

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Who this might be right for
Retinopathy, Diabetic
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT04692688
What this trial is testing

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more
Ocuphire Pharma, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)Ended earlyNCT00248131
What this trial is testing

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 260
Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06321302
What this trial is testing

Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 187
Testing effectiveness (Phase 2)Study completedNCT00198471
What this trial is testing

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

Who this might be right for
Vitreous DetachmentDiabetic Retinopathy
Bausch & Lomb Incorporated 10
Not applicableWithdrawnNCT02309502
What this trial is testing

Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Manchester University NHS Foundation Trust
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Not applicableNot Yet RecruitingNCT05852132
What this trial is testing

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

Who this might be right for
Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao 249
Post-approval studies (Phase 4)Active Not RecruitingNCT06305143
What this trial is testing

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Shanghai Eye Disease Prevention and Treatment Center 58
Not applicableUnknownNCT01759121
What this trial is testing

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Sun Yat-sen University 84
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Large-scale testing (Phase 3)UnknownNCT04511715
What this trial is testing

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences 100
Testing effectiveness (Phase 2)Study completedNCT04722991
What this trial is testing

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Who this might be right for
Diabetic Retinopathy
Bayer 109
Large-scale testing (Phase 3)Ended earlyNCT00600262
What this trial is testing

Intravitreal Bevacizumab for Diabetic Retinopathy

Who this might be right for
Severe NonproliferativeProliferative Diabetic RetinopathyActive Photocoagulated Diabetic Retinopathy
Asociación para Evitar la Ceguera en México
Testing effectiveness (Phase 2)Study completedNCT05383209
What this trial is testing

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Load More Results